NCT04074343 2024-02-02TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal AdenocarcinomaUniversity of California, IrvinePhase 1 Completed20 enrolled 9 charts
NCT02862535 2020-12-24Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction AdenocarcinomaGilead SciencesPhase 1 Terminated36 enrolled 17 charts